These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3523250

  • 21. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 22. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R, Derulska D, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Duczmal B, Jakowicka M.
    Acta Haematol Pol; 1992 Jul; 23(1):43-7. PubMed ID: 1615750
    [Abstract] [Full Text] [Related]

  • 23. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 24. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Buchanan GR, Boyett JM, Pollock BH, Smith SD, Yanofsky RA, Ghim T, Wharam MD, Crist WM, Vietti TJ, Johnson W.
    Cancer; 1991 Jul 01; 68(1):48-55. PubMed ID: 2049752
    [Abstract] [Full Text] [Related]

  • 25. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV, Rivera GK, Look AT, Hustu HO, Kalwinsky DK, Abromowitch M, Mirro J, Ochs J, Murphy SB, Dodge RK.
    J Clin Oncol; 1987 Jul 01; 5(7):1015-21. PubMed ID: 3474355
    [Abstract] [Full Text] [Related]

  • 26. Intensive retreatment of adults and children with acute lymphoblastic leukemia.
    Bassan R, Cornelli PE, Battista R, Terzi F, Buelli M, Rambaldi A, Viero P, D'Emilio A, Dini E, Barbui T.
    Hematol Oncol; 1992 Jul 01; 10(2):105-10. PubMed ID: 1592360
    [Abstract] [Full Text] [Related]

  • 27. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR, Rivera GK, Pollock BH, Boyett JM, Chauvenet AR, Wagner H, Maybee DA, Crist WM, Pinkel D.
    Cancer; 2000 Mar 01; 88(5):1166-74. PubMed ID: 10699908
    [Abstract] [Full Text] [Related]

  • 28. [Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, Armata J, Balcerska A, Balwierz W, Bubala H, Filiks-Litwin B, Kołecki P, Kowalczyk J, Łukowska K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Stencel D, Sonta-Jakimczyk D, Strojny W, Wachowiak J, Wieczorek M, Wysocki M, Zelenay E.
    Med Wieku Rozwoj; 2000 Mar 01; 4(1 Suppl 2):43-8. PubMed ID: 12021461
    [Abstract] [Full Text] [Related]

  • 29. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Sadowitz PD, Smith SD, Shuster J, Wharam MD, Buchanan GR, Rivera GK.
    Blood; 1993 Feb 01; 81(3):602-9. PubMed ID: 8427957
    [Abstract] [Full Text] [Related]

  • 30. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J, Rivera GK, Pollock BH, Buchanan G, Crist W, Freeman AI.
    Cancer; 1990 Oct 15; 66(8):1671-7. PubMed ID: 2208021
    [Abstract] [Full Text] [Related]

  • 31. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
    Dahl GV, Kalwinsky DK, Mirro J, Look AT, Pui CH, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL.
    J Clin Oncol; 1990 Feb 15; 8(2):295-303. PubMed ID: 2299372
    [Abstract] [Full Text] [Related]

  • 32. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Kung FH, Nythan WL, Cuttner J, Falkson G, Lanzkowsky P, Del Duca V, Nawabi IU, Koch K, Pluess H, Freeman A, Burgert EO, Leone LA, Ruymann F, Patterson RB, Degnan T, Hakami N, Pajak TF, Holland J.
    Cancer; 1978 Feb 15; 41(2):428-34. PubMed ID: 272945
    [Abstract] [Full Text] [Related]

  • 33. Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
    Winick N, Buchanan GR, Murphy SB, Yu A, Boyett J.
    Med Pediatr Oncol; 1988 Feb 15; 16(5):327-32. PubMed ID: 3263563
    [Abstract] [Full Text] [Related]

  • 34. Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884).
    Feig SA, Harris RE, Sather HN.
    Med Pediatr Oncol; 1997 Dec 15; 29(6):534-40. PubMed ID: 9324340
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].
    Creutzig U, Schellong G.
    Dtsch Med Wochenschr; 1980 Aug 08; 105(32):1109-12. PubMed ID: 6933063
    [Abstract] [Full Text] [Related]

  • 36. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first remission: a case report.
    Odaka K, Harada M, Koshino T, Yoshida T, Funada H, Nakao S, Ueda M, Kondo K, Ohtake S, Teshima H.
    Nihon Ketsueki Gakkai Zasshi; 1984 Feb 08; 47(1):200-5. PubMed ID: 6377792
    [No Abstract] [Full Text] [Related]

  • 37. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.
    Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R.
    N Engl J Med; 1981 Oct 08; 305(15):846-51. PubMed ID: 7024804
    [Abstract] [Full Text] [Related]

  • 38. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy.
    Pui CH, Bowman WP, Ochs J, Dodge RK, Rivera GK.
    Med Pediatr Oncol; 1988 Oct 08; 16(1):21-6. PubMed ID: 3422333
    [Abstract] [Full Text] [Related]

  • 39. [Intermediate doses of cytosine arabinoside in the treatment of acute non-lymphoblastic leukaemia in children].
    Dluzniewska A, Balwierz W, Moryl-Bujakowska A, Bogusławska-Jaworska J, Dobaczewski G, Januszkiewicz-Lewandowska D, Kołecki P, Kowalczyk J, Krenke K, Matysiak M, Rokicka-Milewska R, Rola-Kurc E, Sońta-Jakimczyk D, Stefaniak MJ, Tomaszewska R.
    Med Wieku Rozwoj; 2000 Oct 08; 4(1 Suppl 2):33-41. PubMed ID: 12021460
    [Abstract] [Full Text] [Related]

  • 40. Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood.
    Steinherz P, Meyers P, Wollner N, Redner A, Tan C.
    Cancer; 1989 Apr 15; 63(8):1472-6. PubMed ID: 2647273
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.